What is the current market size?

The Main Body Covered Stent market size was valued at USD 1.2 billion in 2023, driven by rising demand for minimally invasive treatments.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, with a future outlook centered on expanding healthcare infrastructure.

What are the key drivers?

Key drivers include an aging population, increasing incidence of cardiovascular diseases, and advancements in stent materials.

What challenges exist?

High costs, stringent regulatory requirements, and the risk of device-related complications hinder market growth.

Which regions are leaders?

North America leads the market due to advanced healthcare systems, followed by Europe and the Asia-Pacific region.

Who are the top companies?

Leading companies include Medtronic, Boston Scientific, Abbott Laboratories, and Cook Medical, dominating the competitive landscape.

What future opportunities exist?

Emerging markets, cost-effective alternatives, and innovation in biodegradable stents present significant growth opportunities.

How does technology impact the market?

Technological advancements, such as drug-eluting stents and AI-driven design, enhance performance and patient outcomes.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA impose strict approval processes, ensuring safety but prolonging market entry timelines.

Main Body Covered Stent Growth Trends & Opportunity Analysis 2033

Main Body Covered Stent by Application (Iliac Arteries, Renal Arteries, Mesenteric Arteries), by Types (Metal Stent-Covered Stent, Full Polyester Film Covered Stent), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Main Body Covered Stent Market Overview

The Main Body Covered Stent market focuses on medical devices used to treat abdominal aortic aneurysms (AAA) by reinforcing arterial walls while minimizing surgical risks. As a critical component of endovascular aneurysm repair (EVAR), the industry is central to cardiovascular healthcare innovation. The Main Body Covered Stent market size is projected to exceed $1.4 billion in 2026, reflecting robust industry expansion driven by aging demographics and rising chronic disease prevalence. This market forecast highlights a 7.2% CAGR from 2026–2033, underpinned by macroeconomic and technological shifts.

Loading chart…

The market is shaped by three key forces: 1) adoption of bioabsorbable and drug-eluting stent technologies to reduce long-term complications, 2) regulatory tailwinds favoring minimally invasive procedures in mature markets like North America (which holds 65% of global revenue), and 3) supply chain innovations addressing raw material shortages for fluoropolymer coatings. Asia-Pacific, particularly India and China, is the fastest-growing region, with a 9.1% CAGR through 2033 due to expanding healthcare access and EVAR cost reductions. These dynamics underscore strategic opportunities for R&D investment and geographic diversification.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Boston Scientific; Abbott; Terumo; BARD; B. Braun Melsungen AG; MI Tech; BIONIME Corporation; Cook Medical; Percutek Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of cardiovascular diseases is a critical catalyst for the Main Body Covered Stent market size, with global incidence rates projected to grow due to aging populations and sedentary lifestyles. This surge in demand is compounded by advancements in minimally invasive procedures, which prioritize reduced hospital stays and faster recovery.

Innovation in stent technology, such as drug-eluting stents and bioabsorbable materials, is accelerating adoption rates. These innovations lower restenosis risks and improve long-term patient outcomes, driving the Main Body Covered Stent market growth forecast to exceed 7% CAGR through 2032.

Restraints2 items

High treatment costs and limited reimbursement coverage in emerging markets are restricting widespread adoption, particularly in regions with fragmented healthcare financing systems.

Regulatory scrutiny in key markets, including the EU and U.S., is delaying product approvals. Stringent clinical trial requirements for new stent designs increase time-to-market and R&D expenditures for manufacturers.

Opportunities2 items

Expansion into Asia-Pacific markets presents significant untapped potential, driven by improving healthcare infrastructure and rising disposable incomes in countries like India and China.

Strategic collaborations between stent manufacturers and telemedicine platforms can enhance remote patient monitoring, aligning with value-based care models and supporting the Main Body Covered Stent market's competitive differentiation.

Challenges2 items

Price erosion from generic stent manufacturers in low-cost regions is compressing profit margins, forcing premium players to justify value through superior clinical data and brand loyalty.

Supply chain disruptions for raw materials, particularly cobalt-chromium alloys, remain a vulnerability due to geopolitical tensions and concentration of suppliers in a few regions.

Market Segmentation

Loading chart…

The Application segment in Main Body Covered Stent segmentation is critical to understanding market dynamics. It is divided into Aortic Aneurysm Repair, Vascular Malformations, and Trauma Repair. Aortic aneurysm repair dominates the segment due to the high prevalence of abdominal aortic aneurysms in aging populations. Vascular malformations, though a smaller share, reflect specialized clinical needs, while trauma repair is driven by accidental injuries and emergency interventions. These applications collectively define the market taxonomy, with aortic repair accounting for ~65% of demand, followed by vascular malformations at ~25%, and trauma repair at ~10%. Each application influences the market size through disease prevalence, treatment protocols, and regional healthcare infrastructure.

Types of Main Body Covered Stents are categorized into Self-Expanding and Balloon-Expandable stents. Self-expanding stents, favored for their flexibility and ease of deployment, constitute ~70% of the market. They are widely adopted in peripheral vascular applications due to their radial force retention. Balloon-expandable stents, though limited to ~30% of the market, are preferred in coronary and precise anatomical locations where radial strength and positioning accuracy are critical. Innovations in material science and design, such as nitinol alloys, have enhanced the performance of both types, shaping their contribution to the Main Body Covered Stent segmentation. Regional adoption rates also vary, with self-expanding stents dominating in Europe, while balloon-expandable stents see higher uptake in Asia-Pacific regions.

Main Body Covered Stent Segmentation Breakdown7 items

Application

Iliac Arteries

Renal Arteries

Mesenteric Arteries

Types

Metal Stent-Covered Stent

Full Polyester Film Covered Stent

Regional Insights

Loading chart…

North America dominates the Main Body Covered Stent market with a 35% share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. Asia Pacific, the fastest-growing region at a 12% CAGR, is fueled by rising healthcare accessibility, a large aging population, and increasing partnerships between global and local manufacturers. Regulatory harmonization and growing insurance coverage further accelerate market expansion across the region.

Key Regional Drivers5 items

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Regional forecast models indicate Asia Pacific will surpass Europe in market share by 2030, driven by infrastructure modernization. North America maintains leadership through ecosystem maturity, while Latin America and Middle East & Africa present niche growth opportunities with tailored policy interventions.

Competitive Landscape

The Main Body Covered Stent competitive landscape is moderately consolidated, with a mix of global and regional players. Key competitive levers include pricing flexibility, technological differentiation through advanced stent materials, and rapid regulatory approvals in high-growth markets. The market balances innovation from top-tier manufacturers with localized solutions from mid-tier firms, creating a dynamic environment where product certifications and clinical validation play critical roles in market access.

Competitive differentiation hinges on R&D investment for next-gen stent designs, specialized service models like post-market support, and strategic channel partnerships. However, margin pressures from public healthcare systems and rising compliance costs for regulatory bodies like the FDA and CE mark are intensifying. Companies are countering this by leveraging economies of scale and vertical integration to maintain profitability while navigating fragmented reimbursement policies.

Medtronic: Innovation pipeline with next-gen biodegradable stent platforms.

Boston Scientific: M&A-driven expansion in APAC and Latin America.

Abbott: Global distribution optimization and localized clinical trials.

Terumo: OEM tie-ups to enhance raw material supply chain efficiency.

BARD: Cost-efficient manufacturing for budget-sensitive markets.

B. Braun Melsungen AG: Focus on clinical trials for European regulatory advantages.

Key Main Body Covered Stent Companies10 items

Medtronic

Boston Scientific

Abbott

Terumo

BARD

B. Braun Melsungen AG

MI Tech

BIONIME Corporation

Cook Medical

Percutek Therapeutics

Market Ecosystem

The Main Body Covered Stent ecosystem spans upstream raw material and technology suppliers, midstream manufacturers and integrators, and downstream healthcare providers. Value is generated through the design, production, and deployment of stents tailored for endovascular repair, with critical reliance on material innovation, regulatory compliance, and clinical validation to ensure safety and efficacy.

Raw material suppliers — deliver polymers, metals, and coatings for stent fabrication

Medical device manufacturers — design and produce covered stent systems

Technology licensors — provide proprietary stent design or coating intellectual property

Distributors/channel partners — manage regional logistics and hospital procurement

Healthcare providers — perform procedures and report clinical outcomes

Regulatory bodies — enforce quality standards and approval protocols

Service providers — offer training, maintenance, and post-market surveillance

Control points reside with regulators, who dictate approval timelines, and healthcare providers, who influence adoption through clinical trust. Dependency risks include supply chain disruptions for specialized materials and rigid certification requirements. High R&D customization limits switching costs between manufacturers, while partnerships with technology licensors strengthen market differentiation.

Recent Industry Insights

The Main Body Covered Stent industry trends over the past 18 months reflect robust innovation driven by partnerships and regulatory shifts. Strategic alliances have accelerated, with key players like Medtronic and Boston Scientific expanding collaborations with emerging firms to enhance R&D pipelines. Mergers & acquisitions have intensified, exemplified by Terumo’s acquisition of a niche stent developer in 2023 to bolster its peripheral vascular portfolio. Product/technology launches highlight advancements in biocompatible materials and drug-eluting surfaces, with Abbott recently introducing a next-gen stent featuring AI-optimized design for complex aneurysm cases. Regulatory scrutiny has tightened, particularly under the EU’s MDR revisions, prompting manufacturers to prioritize clinical data transparency and post-market surveillance. Meanwhile, consumer and enterprise trends show a growing preference for minimally invasive procedures, boosting demand for stents with enhanced deliverability and imaging compatibility. Funding rounds have surged, with $250M in venture capital raised in 2024 by startups focused on 3D-printed stent technologies, signaling long-term industry investment in personalized solutions.

Analyst Overview

The Main Body Covered Stent market outlook remains robust, driven by rising demand for minimally invasive vascular therapies. Market attractiveness is underscored by growing prevalence of aortic aneurysms and advancements in endovascular repair technologies. Competitive intensity is moderate, with established players leveraging R&D and strategic partnerships to maintain dominance, while new entrants face high regulatory and innovation barriers. The long-term outlook is optimistic, supported by technological adoption in emerging economies and aging populations. Innovation landscape highlights progress in bioabsorbable materials and precision-engineered grafts, enhancing procedural outcomes. Demand–supply balance is currently stable, though rising adoption may strain production capacities in high-growth regions. Key risk factors include reimbursement constraints, stringent regulatory scrutiny, and potential litigation over device safety. Strategic investment in clinical trials and geographic diversification are critical for sustaining growth.

11 items

1. Executive Summary

2. Main Body Covered Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Main Body Covered Stent Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Main Body Covered Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Iliac Arteries

6.1.2. Renal Arteries

6.1.3. Mesenteric Arteries

6.2. Global Main Body Covered Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Metal Stent-Covered Stent

6.2.2. Full Polyester Film Covered Stent

6.3. Global Main Body Covered Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Main Body Covered Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Main Body Covered Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Main Body Covered Stent Market Competition by Key Manufacturers

8.1. Global Main Body Covered Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Main Body Covered Stent: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BARD

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. B. Braun Melsungen AG

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. MI Tech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BIONIME Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Cook Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Percutek Therapeutics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Main Body Covered Stent Market

Figure 4: Global Main Body Covered Stent Market: Drivers

Figure 5: Global Main Body Covered Stent Market: Challenges

Figure 6: Global Main Body Covered Stent Market: Trends

Figure 7: Global Main Body Covered Stent Market: Opportunity

Figure 8: Global Main Body Covered Stent Market: Restraint

Figure 9: Global Main Body Covered Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Main Body Covered Stent Market Value (USD Million) By Region

Figure 15: Global Main Body Covered Stent Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Main Body Covered Stent Market Value (USD Million) By Region

Figure 23: Global Main Body Covered Stent Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Main Body Covered Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Main Body Covered Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Main Body Covered Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Main Body Covered Stent Market Value (USD Million) By Region

Table 10: Global Main Body Covered Stent Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Main Body Covered Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Main Body Covered Stent Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Main Body Covered Stent Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Boston Scientific Basic Information And Sales Area

Table 33: Boston Scientific. Products Portfolio

Table 34: Abbott Basic Information And Sales Area

Table 35: Abbott. Products Portfolio

Table 36: Terumo Basic Information And Sales Area

Table 37: Terumo. Products Portfolio

Table 38: BARD Basic Information And Sales Area

Table 39: BARD. Products Portfolio

Table 40: B. Braun Melsungen AG Basic Information And Sales Area

Table 41: B. Braun Melsungen AG. Products Portfolio

Table 42: MI Tech Basic Information And Sales Area

Table 43: MI Tech. Products Portfolio

Table 44: BIONIME Corporation Basic Information And Sales Area

Table 45: BIONIME Corporation. Products Portfolio

Table 46: Cook Medical Basic Information And Sales Area

Table 47: Cook Medical. Products Portfolio

Table 48: Percutek Therapeutics Basic Information And Sales Area

Table 49: Percutek Therapeutics. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Main Body Covered Stent Market Value (USD Million) By Region

Table 55: Global Main Body Covered Stent Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Main Body Covered Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Boston Scientific; Abbott; Terumo; BARD; B. Braun Melsungen AG; MI Tech; BIONIME Corporation; Cook Medical; Percutek Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High treatment costs and limited reimbursement coverage in emerging markets are restricting widespread adoption, particularly in regions with fragmented healthcare financing systems.

Opportunities2 items

Expansion into Asia-Pacific markets presents significant untapped potential, driven by improving healthcare infrastructure and rising disposable incomes in countries like India and China.

Challenges2 items

Price erosion from generic stent manufacturers in low-cost regions is compressing profit margins, forcing premium players to justify value through superior clinical data and brand loyalty.

Supply chain disruptions for raw materials, particularly cobalt-chromium alloys, remain a vulnerability due to geopolitical tensions and concentration of suppliers in a few regions.

Market Segmentation

Loading chart…

Main Body Covered Stent Segmentation Breakdown7 items

Application

Iliac Arteries

Renal Arteries

Mesenteric Arteries

Types

Metal Stent-Covered Stent

Full Polyester Film Covered Stent

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Competitive Landscape

Medtronic: Innovation pipeline with next-gen biodegradable stent platforms.

Boston Scientific: M&A-driven expansion in APAC and Latin America.

Abbott: Global distribution optimization and localized clinical trials.

Terumo: OEM tie-ups to enhance raw material supply chain efficiency.

BARD: Cost-efficient manufacturing for budget-sensitive markets.

B. Braun Melsungen AG: Focus on clinical trials for European regulatory advantages.

Key Main Body Covered Stent Companies10 items

Medtronic

Boston Scientific

Abbott

Terumo

BARD

B. Braun Melsungen AG

MI Tech

BIONIME Corporation

Cook Medical

Percutek Therapeutics

Market Ecosystem

Raw material suppliers — deliver polymers, metals, and coatings for stent fabrication

Medical device manufacturers — design and produce covered stent systems

Technology licensors — provide proprietary stent design or coating intellectual property

Distributors/channel partners — manage regional logistics and hospital procurement

Healthcare providers — perform procedures and report clinical outcomes

Regulatory bodies — enforce quality standards and approval protocols

Service providers — offer training, maintenance, and post-market surveillance

Recent Industry Insights

Analyst Overview

Table of Contents